EP Patent

EP0603800A1 — Prostaglandin combinations in glaucoma therapy

Assigned to Alcon Vision LLC · Expires 1994-06-29 · 32y expired

What this patent protects

The invention discloses a topical ophthalmic composition for the treatment of glaucoma and ocular hypertension, said composition comprising a combination of particular prostaglandins of the F and E series.

USPTO Abstract

The invention discloses a topical ophthalmic composition for the treatment of glaucoma and ocular hypertension, said composition comprising a combination of particular prostaglandins of the F and E series.

Drugs covered by this patent

Patent Metadata

Patent number: EP0603800A1
Jurisdiction: EP
Classification: —
Expires: 1994-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Vision LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.